TBGNF
Price:
$0.17
Market Cap:
$229.40K
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV ...[Read more]
Industry
Biotechnology
IPO Date
2007-01-17
Stock Exchange
OTC
Ticker
TBGNF
According to Oxurion N.V.’s latest financial reports and current stock price. The company's current ROE is -0.92%. This represents a change of -102.06% compared to the average of 44.62% of the last 4 quarters.
The mean historical ROE of Oxurion N.V. over the last ten years is 323.35%. The current -0.92% ROE has changed -100.28% with respect to the historical average. Over the past ten years (40 quarters), TBGNF's ROE was at its highest in in the December 2021 quarter at 1.23%. The ROE was at its lowest in in the June 2021 quarter at -166.00%.
Average
323.35%
Median
-11.68%
Minimum
-111.25%
Maximum
2.70%
Discovering the peaks and valleys of Oxurion N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 165.78%
Maximum Annual ROE = 2.70%
Minimum Annual Increase = -2531.37%
Minimum Annual ROE = -111.25%
Year | ROE | Change |
---|---|---|
2024 | -1.08% | -100.75% |
2023 | 143.86% | -79.19% |
2022 | 691.36% | -74.44% |
2021 | 2.70% | -2531.37% |
2020 | -111.25% | 14.11% |
2019 | -97.49% | 165.78% |
2018 | -36.68% | -313.49% |
2017 | 17.18% | -131.28% |
2016 | -54.92% | 146.37% |
2015 | -22.29% | -9.28% |
The current ROE of Oxurion N.V. (TBGNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
278.05%
5-year avg
685.54%
10-year avg
323.35%
Oxurion N.V.’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-0.45%), greater than Blue Water Vaccines, Inc. (-293.56%), greater than PaxMedica, Inc. Common Stock (-1367.11%), greater than Revelation Biosciences, Inc. (-505.44%), greater than Hillstream BioPharma, Inc. (-550.15%), less than Exelixis, Inc. (29.35%), less than TG Therapeutics, Inc. (18.88%), greater than Viking Therapeutics, Inc. (-14.41%), greater than Madrigal Pharmaceuticals, Inc. (-50.54%), less than BioXcel Therapeutics, Inc. (46.69%),
Company | ROE | Market cap |
---|---|---|
-0.45% | $5.06M | |
-293.56% | $3.41M | |
-1367.11% | $12.56K | |
-505.44% | $2.01M | |
-550.15% | $4.17M | |
29.35% | $12.22B | |
18.88% | $6.17B | |
-14.41% | $3.55B | |
-50.54% | $7.66B | |
46.69% | $11.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxurion N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oxurion N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Oxurion N.V.'s ROE?
How is the ROE calculated for Oxurion N.V. (TBGNF)?
What is the highest ROE for Oxurion N.V. (TBGNF)?
What is the 3-year average ROE for Oxurion N.V. (TBGNF)?
What is the 5-year average ROE for Oxurion N.V. (TBGNF)?
How does the current ROE for Oxurion N.V. (TBGNF) compare to its historical average?